Soft Tissue Sarcoma Clinical Trials and Research | Memorial Sloan Kettering Cancer Center
Sarcoma: Continuing the Search for Treatment Alternatives – Consult QD
The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text
World-first clinical trial targets immune molecule IL23 as potential treatment for sarcoma | Garvan Institute of Medical Research
Early Assessment of Masses, Lesions Encouraged by Duke Sarcoma Team | Duke Health Referring Physicians
GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, H2, 2021" provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical
New Treatment Approved for Soft Tissue Sarcoma - NCI
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | Nature Communications
Will Clinical Trials Transform Treatment Options For Sarcoma Patients?
Cancers | Free Full-Text | Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review
Ewing Sarcoma Clinical Trials | Memorial Sloan Kettering Cancer Center
Clinical Trial on Pet Dogs: Breakthrough for Children with Sarcoma
Sarcoma Clinical Trials by Expert Los Angeles Oncologists
Sarcoma Awareness Month: the latest in treatments, clinical trials | City of Hope
Applications Now Being Accepted for Assistance with Clinical Trials Expenses
DOD $1.3M award will launch clinical trial to treat sarcoma - Children's National
Metrics | Early Phase Cancer Trials Programme at UCL and UCLH - UCL – University College London
NIH clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma | National Institutes of Health (NIH)
Patients with a rare and aggressive form of liposarcoma need treatment advances | Boehringer Ingelheim US
Cancer Clinical Trials
Primary and Secondary Endpoints for Sarcoma Clinical Trials
New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC – Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology